Novartis Unveils Mural and Sculpture Exhibition to Raise Awareness of Rare Blood Cancers

Novartis Unveils Mural and Sculpture Exhibition to Raise Awareness of Rare Blood Cancers

Novartis, a multinational pharmaceutical company, has launched a unique mural and sculpture exhibition in London to increase awareness about myeloproliferative neoplasms (MPNs), a group of rare blood cancers. The exhibition features 10 sculptures designed by five talented artists, each representing one of the main symptoms of MPNs. The sculptures aim to educate the public about how these cancers can manifest in the human body.

The interactive installation, located at Westfield London, allows visitors to engage with the sculptures through augmented reality. By interacting with these “characters,” people can gain a better understanding of the symptoms associated with MPNs.

The exhibition was created in collaboration with MPN Voice, a nonprofit organization dedicated to supporting and empowering patients with MPNs. Alisia O’Sullivan, a member of MPN Voice, emphasized the challenges in diagnosing these rare cancers, as their symptoms can often be overlooked or confused with other conditions associated with aging.

Recognizing the importance of early detection and diagnosis, O’Sullivan highlighted the need for increased awareness and identification of MPN symptoms. By identifying these symptoms early, individuals with MPNs can seek appropriate medical assistance to manage their condition effectively, while those who are undiagnosed may receive a potential diagnosis sooner.

MPNs encompass three unique disorders: myelofibrosis (MF), essential thrombocythemia (ET), and polycythemia vera (PV). Each disorder has distinct characteristics and affects the body differently. The “MPN 10” symptoms, including abdominal pain, weight loss, bone pain, fatigue, and night sweats, serve as defining indicators of these blood cancers.

By raising awareness and providing knowledge about MPNs, Novartis aims to empower patients with the information they need to recognize the symptoms and seek appropriate medical care. Marie-Andrée Gamache, the country president at Novartis UK and Ireland, emphasized the company’s commitment to positively impacting the lives of individuals living with blood cancers through this initiative. The collaboration with talented artists allows for the effective portrayal of the reality and impact of MPN symptoms, drawing attention to the cause in a powerful and creative way.

– MPN Voice:

All Rights Reserved 2021.
| .